Subjects: H.R.3116 — 113th Congress (2013-2014)

  • Administrative law and regulatory procedures
  • Administrative remedies
  • Advisory bodies
  • Department of Health and Human Services
  • Drug safety, medical device, and laboratory regulation
  • Drug therapy
  • Executive agency funding and structure
  • Food and Drug Administration (FDA)
  • Government studies and investigations
  • Health
  • Intellectual property
  • Medical research
  • Medical tests and diagnostic methods
  • Medicare
  • Prescription drugs